Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8098622

Download in:

View as

General Info

PMID
8098622